CIK: 1564778 - Address: 250 Campus Drive, Marlborough, MA 01752
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/14/18 16:09
2/13/18
HOLXHologic IncDEHealthOthMdX-Ray Apparatus & Tubes & RelNawana NamalMADP25037.8807999%7D
6/16/17 18:50
1/15/17
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.0005052146D
2/21/17 18:21
2/16/17
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.00234747148D-8-2505284-10-1-4
11/2/16 19:17
10/31/16
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.00191716119D11-7101923-1-1-4-19-10-1312
3/2/16 17:23
2/3/16
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.00335083110D46151285110-100-6-20-27-30
1/4/16 17:10
12/30/15
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.002210081D83-28-22-3-1100-936282-2
11/3/15 21:38
10/31/15
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.00261716D4119-3-9-8534-1-11-1214-14-6
1/2/15 13:52
12/30/14
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMADOCEOM.d00.001655546D1055-4-2-54-12-14729423
1/2/14 18:03
12/30/13
ALRAlere Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNawana NamalMAOCOOM.d00.001751D589646159612075-3105

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact